Punit Dhillon's extensive experience led him to co-found and serve as President and CEO of OncoSec Medical Inc. (NASDAQ: ONCS), a biotechnology company pioneering new technologies to fight cancer. Since moving on from this role, he has worked in various management capacities and helped to raise $500M for several companies, working together to reach essential milestones. His experience spans corporate finance, M&A, integration, successful in-licensing of key intellectual property, strategy implementation, international corporate transactions, and collaborations with leading universities and key opinion leaders. Today, Punit is the chairman and CEO of SKYE Bioscience Inc., a public pharmaceutical company. He also serves on the board of directors of other life science companies and acts as an advisor and consultant in several capacities to different life science organizations. He is the creator of Torpedo Publishing, a publishing imprint serving to connect, inspire, and educate future game changers looking to positively impact the world. Punit is the recipient of the Most Admired CEO award by the San Diego Business Journal in 2017, the BIOCOM Catalyst Award in 2018, the BASS Community Impact Award (SFU Beedie School of Business) in 2018, and has been recognized as a finalist for Ernst & Young's Annual Entrepreneur of the Year in 2014. Connect with Jon Dwoskin: Twitter: @jdwoskin Facebook: https://www.facebook.com/jonathan.dwoskin Instagram: https://www.instagram.com/thejondwoskinexperience/ Website: https://jondwoskin.com/LinkedIn: https://www.linkedin.com/in/jondwoskin/ Email: [email protected] Get Jon's Book: The Think Big Movement: Grow your business big. Very Big! Connect with Punit Dhillon: Website: www.skyebioscience.com Twitter: https://twitter.com/PunitDhillon Instagram: https://www.instagram.com/punitdhillon/ LinkedIn: https://www.linkedin.com/in/punit-dhillon/ Facebook: https://www.facebook.com/punit.dhillon27

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related